Source:http://linkedlifedata.com/resource/chebi/id/CHEBI:3238
| Predicate | Object |
|---|---|
| rdf:type | |
| skos:definition |
"Trimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in fungal cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections." []
|
| skos:inScheme | |
| skos:prefLabel |
butenafine
|
| skos:altLabel |
1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine,
Butenafine
|
| skos:notation |
Beilstein:6334654 "Beilstein Registry Number",
ChEMBL:17371821 "PubMed citation",
ChEMBL:8340915 "PubMed citation",
DrugBank:DB01091 "DrugBank",
KEGG COMPOUND:101828-21-1 "CAS Registry Number",
KEGG COMPOUND:C08067 "KEGG COMPOUND",
KEGG DRUG:D07596 "KEGG DRUG",
Patent:EP164697 "Patent",
Patent:US5021458 "Patent",
Wikipedia:Butenafine "Wikipedia"
|
| skos:broader | |
| skos:relatedSynonym |
butenafine,
butenafinum,
butenafina,
4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine,
N-(p-tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine,
(4-tert-Butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine,
(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine,
C23H27N,
CN(Cc1ccc(cc1)C(C)(C)C)Cc1cccc2ccccc12,
InChI=1S/C23H27N/c1-23(2,3)21-14-12-18(13-15-21)16-24(4)17-20-10-7-9-19-8-5-6-11-22(19)20/h5-15H,16-17H2,1-4H3,
InChIKey=ABJKWBDEJIDSJZ-UHFFFAOYSA-N
|